SCHEMBL22203802

SCHEMBL22203802

O=c1c2cc3c(=O)n(Cc4ccccc4)c(=O)c3cc2c(=O)n1Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.62
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
KDM4E B2RXH2 3/20 0.58
CA12 O43570 2/20 0.58
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
CA9 Q16790 2/20 0.58
HPGD P15428 1/20 0.58
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
MAPT P10636 3/20 0.55
LMNA P02545 2/20 0.55
GSK3A P49840 1/20 0.55
GSK3B P49841 1/20 0.55
P2RX4 Q99571 1/20 0.55
RAB9A P51151 2/20 0.53
MAPK8 P45983 2/20 0.53
MAPK9 P45984 2/20 0.53
RECQL P46063 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13259493 0.94 SRC (0.57) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL24439296 0.91 SRC (0.58) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL12895967 0.91 SRC (0.54) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL12895946 0.90 SRC (0.57) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL24438890 0.89 ALDH1A1 (0.57) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL29674648 0.89 ALDH1A1 (0.57) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL14392803 0.87 ALDH1A1 (0.67) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL12895971 0.87 ALDH1A1 (0.58) SRCALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL12895972 0.86 SRC (0.50) SRCALDH1A1SMN1; SMN2KDM4ECA12
SCHEMBL12895968 0.86 MEN1 (0.55) SRCALDH1A1SMN1; SMN2KDM4ECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11789307-B2 Colorant filter, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2023-10-17 US disclosed
US-11789307-B2 Colorant filter, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2023-10-17 US disclosed
US-11733435-B2 Polarizing plate protective film, polarizing plate, and liquid crystal display device FUJIFILM CORPORATION (JP) 2023-08-22 US disclosed
US-11733435-B2 Polarizing plate protective film, polarizing plate, and liquid crystal display device FUJIFILM CORPORATION (JP) 2023-08-22 US disclosed
US-20230012898-A1 LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-01-19 US disclosed
WO-2021162115-A1 LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE 富士フイルム株式会社 2021-08-19 WO disclosed
US-20210026199-A1 COLORANT FILTER, BACKLIGHT UNIT, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2021-01-28 US disclosed
US-20210005673-A1 COLOR CORRECTION FILTER FOR WHITE ORGANIC ELECTROLUMINESCENT LIGHT SOURCE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2021-01-07 US disclosed
US-20200217993-A1 POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230012898-A1 LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE EPCAM, ICAM1, STRA6 SRC 3411/4885ALDH1A1 201/4885SMN1; SMN2 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.